Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran

Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran Publisher Pubmed

Balighi K^{1, 2} ; Mousavi A¹ ; Hatami P¹ ; Daneshpazhooh M^{1, 2} ; Ghiasi M^{1, 2} ; Kamyab Hesari K^{1, 3} ; Aryanian Z^{1, 4}

Show Affiliations

1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Dermatopathology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran

Source: Dermatologic Therapy Published:2022

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum, Dermatologic Therapy (2022)

2. Sars-Cov-2 Vaccination and Practical Points in Psoriasis Patients: A Narrative Review, Dermatologic Therapy (2022)

3. Dexamethasone or Prednisone: Which One Should Be the Corticosteroid of Choice in Patients With Pemphigus Vulgaris?, Dermatologic Therapy (2022)

4. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)

5. Kaposi's Sarcoma in a Patient With Pemphigus Vulgaris Mimicking Exacerbation of Pemphigus, Cancer Reports (2023)

6. Rituximab As a Maintenance Treatment in Patients With Pemphigus Vulgaris: When Is the Right Time for Discontinuation?, Journal of Cosmetic Dermatology (2024)

7. Serious Health Threat of Mucormycosis During the Ongoing Covid-19 Pandemic: What Dermatologists Need to Know in This Regard, International Journal of Dermatology (2022)

8. Multiple Cycles of Rituximab Therapy for Pemphigus: A Group of Patients With Difficult- To-Treat Disease or a Consequence of Late Rituximab Initiation?, Dermatologic Therapy (2022)

Experts (# of related papers)

View all Related Experts

Zeinab Aryanian (11)

Kamran Balighi (11)

Style	Citing Format
MLA	Balighi K, et al.. "Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran." Dermatologic Therapy, vol. 35, no. 8, 2022, pp. -.
APA	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Kamyab Hesari K, Aryanian Z (2022). Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran. Dermatologic Therapy, 35(8), -.
Chicago	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Kamyab Hesari K, Aryanian Z. "Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran." Dermatologic Therapy 35, no. 8 (2022): -.
Harvard	Balighi K et al. (2022) 'Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran', Dermatologic Therapy, 35(8), pp. -.
Vancouver	Balighi K, Mousavi A, Hatami P, Daneshpazhooh M, Ghiasi M, Kamyab Hesari K, et al.. Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran. Dermatologic Therapy. 2022;35(8):-.
BibTex	@article{ author = {Balighi K and Mousavi A and Hatami P and Daneshpazhooh M and Ghiasi M and Kamyab Hesari K and Aryanian Z}, title = {Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran}, journal = {Dermatologic Therapy}, volume = {35}, number = {8}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Balighi K AU - Mousavi A AU - Hatami P AU - Daneshpazhooh M AU - Ghiasi M AU - Kamyab Hesari K AU - Aryanian Z TI - Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran JO - Dermatologic Therapy VL - 35 IS - 8 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract